- Supported exchanges /
- SHE /
- 300723.SHE
Yipinhong Pharmaceutical Co Ltd Class A (300723 SHE) stock market data APIs
ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drop, montelukast sodium granule, acyclovir for injection, and oseltamivir phosphate capsule products. The company's chronic disease drugs comprise hepatocyte growth stimulating hormone and pentoxifylline for injections, kangshen granules, uqingshu granules, shenbai lotion products, compound monoammonium glycyrrhizinate S and lansoprazole for injections, houttuynia sodium tablets, omeprazole sodium and bromhexine hydrochloride for injections, huixinkang tablets, amlodipine benzenesulfonate dispersible tablets, yanhunin and sodium ferulate for injections, cyclic adenosine phosphate and ambroxol hydrochloride for injections, valsartan amlodipine tablets, and nifedipine controlled release tablets, as well as tricorutin, aceglutamide, vinpocetine, and doxofylline for injections. In addition, it offers compound xiangrui water, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; venlafaxine hydrochloride sustained-release capsules; and levofloxacin hydrochloride, sodium ozagrel, brain protein hydrolysate, and ganciclovir for injections. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.
Yipinhong Pharmaceutical Co Ltd Class A Financial Data Overview
| 16.47 | |
| 17.65 | |
| - | |
| 17.66 | |
| 16.44 | |
| 12.74-31.7027 | |
| 7 439 M | |
| 452 M | |
| 1 893 M | |
| -0.6487 | |
| 0.0128 | |
| 0.574 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Yipinhong Pharmaceutical Co Ltd Class A Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 893 M
- EBITDA 215 M
- Earnings Per Share -0.75
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Yipinhong Pharmaceutical Co Ltd Class A Earnings via APIs
- Latest Release 2024-10-29
- EPS/Forecast NaN
Get Yipinhong Pharmaceutical Co Ltd Class A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
